Jazz Pharmaceuticals Reports Q1 2025 Results: Revenue Growth Amid Strategic Advances and Market Challenges
Jazz Pharmaceuticals reported Q1 2025 revenues of $898 million, driven by growth in key products, but fell short of earnings estimates, sparking discussions about its valuation and future prospects.
2 minutes to read